Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

Mefenamic acid - Generic Drug Details

« Back to Dashboard

What are the generic sources for mefenamic acid and what is the scope of mefenamic acid freedom to operate?

Mefenamic acid
is the generic ingredient in two branded drugs marketed by Vintage Pharms Llc, Lupin Ltd, Shionogi Inc, Breckenridge Pharm, and Micro Labs Ltd, and is included in five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for mefenamic acid. Seven suppliers are listed for this compound.

Summary for Generic Name: mefenamic acid

Tradenames:2
Patents:1
Applicants:5
NDAs:5
Drug Master File Entries: see list13
Suppliers / Packagers: see list7
Bulk Api Vendors: see list79
Clinical Trials: see list2,080
Patent Applications: see list6,102
Therapeutic Class:Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:mefenamic acid at DailyMed

Pharmacology for Ingredient: mefenamic acid

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Breckenridge Pharm
MEFENAMIC ACID
mefenamic acid
CAPSULE;ORAL090359-001Feb 5, 2013ABRXNoNo► Subscribe► Subscribe
Micro Labs Ltd
MEFENAMIC ACID
mefenamic acid
CAPSULE;ORAL090562-001Nov 19, 2010ABRXNoNo► Subscribe► Subscribe
Lupin Ltd
MEFENAMIC ACID
mefenamic acid
CAPSULE;ORAL091322-001Jul 22, 2011ABRXNoNo► Subscribe► Subscribe
Shionogi Inc
PONSTEL
mefenamic acid
CAPSULE;ORAL015034-003Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe
Vintage Pharms Llc
MEFENAMIC ACID
mefenamic acid
CAPSULE;ORAL091608-001Jun 2, 2014ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot